Bristol-Myers to cut another 100 jobs; German court invalidates patent on AZ's Seroquel XR;

@FiercePharma: $AZN's Seroquel franchise takes another hit: German court rules XR patent invalid. U.K. did already. Anyone else? More | Follow @FiercePharma

> Bristol-Myers Squibb ($BMY) plans to cut another 100 or so jobs in sales and support functions, soon after disclosing plans to slash 480 from its New Jersey payroll. Report

> AstraZeneca's ($AZN) Seroquel XR, the long-acting version of its newly off-patent antipsychotic drug, saw its patent invalidated in Germany, where it brought in $82 million so far this year. Report

> A group of experts arguing for a global treaty to stop counterfeit drugs was barred from an upcoming WHO meeting. Report

> Cardiologists are weighing the cost of heart disease treatments as prices for drugs and devices set records and insurers ratchet back reimbursements. Report

> Sagent Pharmaceuticals ($SGNT) launched a generic version of the injectable edema and glaucoma treatment Diamox. Report

Medical Device News

 @FierceMedDev: Medtronic gains expanded approval for ts Valiant Captivia stent graft system. More | Follow @FierceMedDev

 @MarkHFierce: Malaysia looking to beef up its medical device clinical testing capabilities. Item | Follow @MarkHFierce

 @DamianFierce: Mindray Medical is recalling anesthesia devices over a leak risk. News | Follow @DamianFierce

> FDA blocks Hospira from importing pumps. Article

> Edwards crushes Medtronic in appeals fight over heart valve patent. Story

Biotech News

 @FierceBiotech: Protein biomarker predicts Type 2 diabetes years in advance. Story | Follow @FierceBiotech

 @JohnCFierce: Want to sell expensive cancer drugs in China? Get the middle class to buy health insurance. Via BMBG. Story | Follow @JohnCFierce

 @RyanMFierce: HepC pill race report 2012: $GILD, $ABT, $VRTX, others rush toward pharma gold. Report | Follow @RyanMFierce

> Pharma groups advance 221 new diabetes drugs as epidemic worsens. Article

> Bayer gambling $4B R&D budget on Xarelto, top blockbuster hopefuls. Story

Biomarkers News

> Biomarker tags AstraZeneca's clot buster activity in patient subgroup. Story

> Genetic mutations signpost inherited heart risk. Item

> Protein marker tags activity for GlaxoSmithKline drug in mesothelioma. More

> Fox Foundation funds BioFIND Parkinson's marker project. News

Drug Delivery News

> Injectable sponge stars and hearts deliver drugs. Story

> Optinose $2.1M grant to deliver autism treatment from the nose to the brain. Item

> Bacterial 'minicells' deliver cancer drugs straight to the target. More

> GSK, XenoPort terminate extended-release gabapentin deal. Article

And Finally... Greece's malaria outbreak has been exacerbated by the country's crippled public health system. Report (sub. req.)